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Abstract 
 
The aim of this study was to design an individualised questionnaire to measure the 
impact of macular disease (MD) on quality of life (QoL). Principles underlying the 
SEIQoL interview method and the ADDQoL diabetes-specific questionnaire 
influenced the MacDQoL design. 
 
The MacDQoL specifies domains of QoL that were selected using focus group 
methodology and refined following a postal pilot study of members of the UK 
Macular Disease Society. Respondents rated the impact of MD on each domain 
and the importance of each domain to their QoL. 
 
Mean domain scores from 69 respondents indicated that MD had a negative impact 
on all the domains of QoL investigated in the measure. There was preliminary 
evidence of good internal consistency reliability (Cronbach’s alpha=0.93, n=37). 
Respondents who were registered partially sighted or blind reported poorer QoL 
than those who were not registered (Kruskal Wallis: X2 = 14.03, N = 62, p < 0.001). 
This evidence suggests that the measure will be sensitive to subgroup differences. 
The instrument has been further refined following the pilot study. The MacDQoL is 
being used in clinical trials and psychometric evaluation of the measure will be 
carried out using trial data. The measure is available for clinical use and has been 
linguistically validated in fifteen other languages. 
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Abbreviations: 
 
ADDQoL:  Audit of diabetes-dependent quality of life 
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FS: functional status 
 
HS: health status 
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MacDQoL: Macular disease-dependent quality of life measure 
 
MD-QoL: MD-specific quality of life 
 
MD: macular disease 
MDS: Macular Disease Society 
 
MDSQ: Macular Disease Society Questionnaire 
 
P/S: Partially sighted 
 
QoL: quality of life 
 
SEIQoL: Schedule for the evaluation of individual quality of life 
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Introduction 
 
 
Macular disease (MD) is a chronic, degenerative eye condition. It affects the central 
part of the retina, the macula, and results in loss of central vision. Peripheral vision 
is retained, but loss of acuity can be severe and sufficient for registration as blind. 
The condition most often affects people over the age of 50 years, when it is 
commonly referred to as age-related macular degeneration. Incidence increases 
with age. It is the most common cause of blindness in those aged over 60 years, 
and is the cause of 95% of new registrations as blind and partially sighted in that 
age group in the UK [1]. There are two types of MD. Dry MD, for which there is 
currently no treatment, progresses more slowly and it accounts for approximately 
85% of all cases of MD. The more rapidly progressing wet MD affects about 15% of 
cases.  A proportion of these may be treatable with photodynamic therapy, which 
has recently been approved for use in many countries, or with other, less 
successful treatments, including laser photocoagulation. For the majority of people 
with MD, management is limited to rehabilitation and low vision aid provision. With 
new treatments now being developed and evaluated, however, there is a pressing 
need for appropriate psychological outcome measures in the assessment of both 
medical and non-medical interventions. 
 
The importance of measuring quality of life (QoL) in health care is increasingly 
recognised [2]. Often, however, instruments that are used to measure the construct 
would be more appropriately referred to as measures of health status (HS) or 
functional status (FS) [3].  HS instruments measure the quality of health rather than 
the QoL [4] while a visual function measure indicates the impact of vision loss on 
functioning rather than the perceived impact of vision loss on QoL [5]. Whereas HS 
and FS are related to QoL, they are not themselves measures of QoL. People do 
not all regard aspects of HS or FS as equally important to QoL, and some may be 
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regarded as not at all important. Therefore, when scores of perceived functional 
ability in a number of different areas are simply added together, this does not 
realistically represent a measure of an individual’s QoL. Measuring HS and FS can 
be valuable in estimating the impact of medical conditions and their treatment but, 
as Joyce [6] commented,  ‘it is not the observed functioning of the individual that is 
of primary concern, but that individual’s perceptions of and reactions to functioning’ 
(p46). In ophthalmology, as elsewhere, clinicians recognise the value of measuring 
the impact of medical and rehabilitative interventions on QoL. As visual impairment 
may have an effect on length of life only indirectly (perhaps through falls, accidents 
or suicide) its impact is primarily on QoL [7]. Here too, in the ophthalmological 
literature, the distinction between FS, HS and health related QoL (HRQoL) is often 
overlooked. Measures of FS and HS are misused as measures of HRQoL (e.g. 
reference 7) and the terms are sometimes used interchangeably (e.g. reference 8). 
Studies that focus more specifically on MD that have purported to measure QoL or 
HRQoL, have used measures that actually assess FS or HS [9, 10, 11]. But visually 
impaired people do not necessarily regard visual impairment as a form of health 
impairment. For example, Mangione, Gutierrez , Lowe et al [9] reported that the SF-
36 did not correlate with severity of MD. The SF-36 was also found to be 
unresponsive to changes in visual acuity over a two-year period in people with MD 
[12].  Bradley [4] commented that, when unsuitable measures are used to assess 
QoL, the interpretation of the data may be misleading and she emphasised the 
importance of enabling the individual’s view of QoL to be measured. Joyce (6) 
noted that there is confusion about the use and meaning of the terms HS, FS and 
HRQoL. Since the term HRQoL has been so misused and, since conditions such 
as MD are not usually viewed as an aspect of health by individuals who have the  
condition, we prefer to use the term ‘condition-specific quality of life’ (C-SQoL) 
when referring to QoL as it is affected by a medical condition, and ‘MD-specific 
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quality of life’ (MD-QoL) when referring to QoL as it is impacted specifically by MD. 
This ensures that they are not confused with the terms HS and FS. 
 
The Schedule for the Evaluation of Individual Quality of Life (SEIQoL) [13], is an 
individualised measure of QoL that differs fundamentally from previous measures. 
Earlier measures tend to consist of domains that have been derived from the views 
of researchers, health professionals or even other patients, but not from the 
individual patients themselves. The SEIQoL allows individual respondents to name 
five domains of life that they perceive to be the most important to their own QoL. 
The individual rates the present quality of each of those domains and the relative 
importance of each one to their overall QoL. The importance ratings are used to 
weight the domain ratings and the weighted ratings are summed to provide a single 
QoL score. A similar approach has been used in the Patient Generated Index [14] 
which is condition-specific in that it asks patients to name the five areas of their life 
that are most affected by their medical condition. Importance ratings are indirectly 
incorporated. Again, the relevance of domains for the patient is paramount. 
Weighting an assessment criterion by an ‘importance’ value is a strategy used in 
multi-criteria decision making (15). In a decision-making situation, multiple criteria 
are used to lead a decision-maker to his/her most desired solution to a problem. In 
QoL measures that use multiple criteria to assess domains of the measure, the 
purpose is to enable participants to indicate more accurately the impact of any 
situation (e.g. a chronic medical condition) on their QoL. 
 
The philosophy underpinning the SEIQoL was adopted by Bradley and her 
colleagues in the development of an individualised diabetes-specific measure of 
QoL, the Audit of Diabetes-dependent Quality of Life (ADDQoL) [16]. Interviews 
with people with diabetes, together with research literature and experience, were 
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used to determine domains of life impacted by diabetes and important for QoL. In 
the interviews, participants were asked to specify ways in which their QoL would be 
affected if they were to find they no longer had diabetes. Eighteen domains are 
now included in the ADDQoL [17]. Those items in the ADDQoL that might not be 
relevant to all include a ‘not applicable’ option. Participants rate the impact of each 
applicable domain on a scale of –3 to +3 where 0 indicates that the particular 
domain would be ‘the same’ if they did not have diabetes. Participants then rate the 
importance of domains for QoL from 0 (not at all important) to 3 (very important). 
The ADDQoL includes two overview items. The first asks about QoL per se and the 
second asks about the impact of diabetes on QoL. Psychometric development work 
[16,17] provided support for the inclusion of importance ratings and included the 
finding that the full range of importance ratings (0, 1, 2 and 3) were used for all 
domains. A growing body of evidence attests to the value of the ADDQoL (e.g. 16, 
17, 18, 19, 20). A similar measure has been developed for use with adults with 
renal failure  [21] and adults with growth hormone deficiency [22]. 
 
In the work reported here the researchers set out to design an individualised, MD-
specific measure of QoL, suitable for people with all types of MD. They were guided 
by the philosophy underpinning the SEIQoL, ADDQoL and related measures which 
incorporate participants’ views of the importance of domains of life to their QoL. 
The ADDQoL format and the more generic items contained within it (e.g. domains 
concerning work, family, friends and social life) provided a useful starting point in 
the development of the Macular Disease-dependent Quality of life (MacDQoL) 
measure. 
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Method 
 
 With the collaboration of a person who has MD, and with reference to the research 
literature and to data from a survey of 1420 members of the UK MD Society (MDS) 
[23],  the authors designed a first draft of the MacDQoL. Generic items from the 
ADDQoL were modified for MD e.g. ‘If I did not have diabetes (macular disease), 
my family life would be’.  ADDQoL domains that were not appropriate to people 
with MD were omitted e.g. ‘If I did not have diabetes, my freedom to eat as I wish 
would be’. Composite domains from the ADDQoL, that were likely to encompass 
greater proportions of time in the mostly retired MD population, were subdivided 
into two separate domains e.g. ’holidays and leisure’ became both ‘holidays’ and 
’hobbies and leisure activities’. Finally, new domains were added that were 
appropriate to people with MD e.g. ‘correspondence and personal affairs’, 
‘domestic tasks’.  Two overview items similar to those in the ADDQoL, one generic 
(‘In general, my quality of life is’: excellent – extremely bad) and one MD-specific (‘If 
I did not have MD, my quality of life would be’: very much better – very much 
worse), were included in the MacDQoL.  
 
The layout of the MacDQoL was designed to enable self-completion by people with 
MD. Arial font size 16 (bold) was used. All text was justified to the left, and the use 
of capital letters was avoided except where dictated by grammar. Heavy dotted 
lines led from the end of each statement to the response boxes. Instructions were 
enclosed in solid line boxes. Each item was contained on a separate page of the 
questionnaire and included two parts: the impact rating and the importance rating. 
The format of a domain-specific item of the MacDQoL is shown in Figure 1 though, 
prior to first use in focus groups, there were seven response options on the impact 
scale (as was the case for the ADDQoL): very much better, much better, a little 
better, the same, a little worse, much worse, very much worse. 
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(Figure 1 about here) 
 
 
The first draft of the MacDQoL was tested during meetings at two local groups of 
the MDS. There were 6 participants at the first meeting and 11 at the second. 
There were four parts to each meeting: 
 
1. Using a statement similar to that used for participants in the ADDQoL 
interviews, group members were told: 
 
“ Imagine you wake up tomorrow morning and discover that, by some magic, 
you no longer have macular disease and your central vision has been restored. 
In what important ways would that affect your quality of life?” 
 
Participants wrote down ways in which their QoL would change. Help was given 
to participants who were unable to see well enough to write. 
2. Participants completed the draft MacDQoL. In some cases visual impairment 
meant help was required to complete the questionnaire. Help consisted of 
reading out the items and response options and/or entering the participants’ 
responses on the questionnaire as necessary. Some people who were helped 
needed entire items reading out, others had difficulty with occasional words. 
3. Participants discussed the MacDQoL and their ideas in small groups while the 
researchers reviewed lists generated in (1) and the questionnaires completed in 
(2). Domains mentioned in (1) but not yet included in the MacDQoL were 
identified, as were items in the MacDQoL that were not important or not 
impacted by MD. 
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4. A general discussion of the MacDQoL and QoL in people with MD was chaired 
by a researcher (CB). During the discussion, missing items and irrelevant items 
were identified and considered and wording for new items devised. 
  Domains used in the first draft of the MacDQoL are shown in Table 1 
 
(Table 1 about here) 
 
Following the 2 local group meetings and analysis of findings, changes were made 
to the measure: 
• Participants had questioned the need for any measure of positive impact, 
saying that there were no ways in which MD could make a positive impact on 
QoL. It is possible, however, that there may be a positive impact in some 
domains, such as social life, which might improve for a lonely individual who 
joins a self-help group and makes new acquaintances there. Registration as 
blind entitles people to financial assistance, which may improve finances for 
some. It was agreed, however, that only one level of positive impact was 
necessary both for the domain-specific items and the MD-specific overview 
item.   
 
• Three new items were added to the measure. Several group members said 
shopping was troublesome. Apart from the difficulty of identifying products and 
prices and handling money, the pleasure had gone from shopping.. The time 
taken to do things was a source of frustration for some, as was the risk of losing 
things or of mishaps such as dropping or spilling things.  
 
A postal pilot was used to test the second draft of the MacDQoL. The measure was 
sent to 65 members of the MDS randomly selected from those completing the 
MDSQ survey [23] in earlier work who had expressed a willingness to take part in 
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subsequent studies. The MDSQ had a response rate of 71%, of whom 81% had 
indicated that they were willing to participate in further studies. The high response 
rate suggested that respondents were a representative sample of members of the 
MDS. Written consent was obtained, in accordance with the Helsinki Declaration. In 
addition, further data were collected using the second draft at a third MDS local 
group (5 participants) during the testing of an electronic data collection system. 
 
The data from the 69 participants were entered on SPSS 9.0. These were collected 
from all phases of the development work. A breakdown of the sources of data is 
shown in Figure 2. There were 51 women and 17 men (one did not specify sex).  
The mean age of the sample was 76.6 years (range 39 – 100, s.d. 12.2).  Eleven 
people had MD in only one eye and 52 people reported bilateral involvement (no 
data for 6 people). Twenty-eight people were registered blind, 18 were partially-
sighted and 16 were not registered (no data for 7) (In the UK this is generally 
assessed using the familiar optometrist’s chart, known as  the ‘Snellen’ chart. 
People who cannot read the top line of the chart have a visual acuity that makes 
them eligible for registration as blind. Those who can read only the top line of the 
chart are eligible for registration as partially sighted). The missing data are due to 
the fact that members of the first two local groups were not asked for full details of 
their MD, although some gave unsolicited information on their questionnaires. 
 
(Figure 2 about here) 
 
Scoring 
The impact of MD on each domain is scored from –3 (high negative impact) 
through 0 (no impact) to +1 (positive impact). Importance is scored from 0 (not at all 
important) to 3 (very important). A weighted impact score for each domain is 
obtained by multiplying impact ratings by importance ratings. Some domains have 
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a ‘not applicable’ option. Where a participant indicates that a domain is not 
applicable to him/her, the impact and importance ratings are not completed. An 
average weighted impact score is obtained by summing all weighted impact scores 
and dividing by the number of applicable domains rated. The generic QoL overview 
item is scored from –3 (extremely bad) through 0 (neither good nor bad) to +3 
(excellent). The MD-specific overview item is scored from –3 (high negative impact 
of MD on QoL) through 0 (no impact of MD on QoL) to +1 (positive impact of MD on 
QoL). 
 
 
Results 
 
The second version of the MacDQoL contained 5 items that were newly designed 
for the instrument, two that were modified from ADDQoL items and 15 items that 
were taken directly from the ADDQoL (Table 1). Fifteen of the items in the measure 
were mentioned spontaneously by participants in the two focus groups (Table 1). 
 MD had a negative impact on every domain in the MacDQoL. Table 2 shows the 
mean impact scores in descending order of impact. The mean importance ratings 
are also shown together with the position of each domain in order of weighted 
impact. The rankings of the domains were changed in some cases after the impact 
ratings were weighted. The full range of importance ratings was used in 14 of the 
22 domains (Table 2). A positive impact of MD was indicated by single participants 
in each of 4 domains and by 2 participants in one domain (‘society’s reaction’) 
(Table 2). 
 
(Table 2 about here) 
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Scrutiny of the raw data revealed that impact scores and importance ratings were 
often the same, other than when either score was zero.  Correlations between 
impact and importance scores ranged between –0.195 (correspondence and 
personal affairs) and 0.865 (worries about the future) (Table 3). When cases with 
zero scores for either impact or importance were removed, the correlation between 
the weighted impact score and the importance score was very high in all domains 
except work (Table 3).  It was considered that a simpler use of the data, which 
might achieve equivalent results, would be to change to zero any impact scores for 
which the corresponding importance score was zero, and then analyse the impact 
scores rather than the product of impact and importance scores.  This procedure 
was carried out for all domains. Using this method, the rank order of domains 
remained the same as that of the unweighted impact scores with two exceptions: 
Domains 4 and 5 (‘shopping’ and ‘hobbies and leisure activities) were reversed and 
domains 13 and 14 (worries about the future’ and ‘friends and social life’) were 
reversed.  
 
The mean weighted impact scores are shown in Figure 3. The greatest mean 
weighted impact score is for ‘work and work-related opportunities’ (-7.42), followed 
by ‘correspondence and personal affairs’ (-6.54). The data show that MD had the 
least impact on ‘finances’ (-1.20) and sex life (-0.73) in this sample. 
 
 
Figure 4 shows the mean weighted impact scores of domains common to the 
MacDQoL and the 18-item ADDQoL. These two measures are scored in the same 
way except that the ADDQoL has three levels of positive impact, whereas the 
MacDQoL has only one level of positive impact. For comparison purposes, any 
positive ADDQoL scores were recoded as 1.  With the exceptions of the domains 
‘enjoyment of food’ and ‘sex life’, MD had a greater negative impact on QoL than 
did diabetes in all domains that the two questionnaires had in common. 
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 (Figures 3 and 4 about here) 
 
Justification for the inclusion of domains in the scale and for combining them to 
achieve an average weighted score was sought by carrying out internal 
consistency reliability analysis (Cronbach’s alpha). With all items included, the 
alpha coefficient was 0.92. Alpha-if-item-deleted statistics showed that the alpha 
coefficient would be improved by the omission of ‘sex life’, ‘living conditions’, ‘work’ 
and ‘finances’. It was decided to remove only ‘sex life’ and ‘living conditions’ at this 
early stage. The influence of the domain ‘work’ on the reliability may have been due 
to the small number of people (n = 7) for whom the domain was applicable. 
‘Finances’ had a high negative impact for a few people, and it was decided to leave 
that domain in the questionnaire until it has been further evaluated. The new alpha 
coefficient, after removal of ‘sex life’ and ‘living conditions’, was 0.93.   
 
The sensitivity of the MacDQoL to subgroup differences was investigated by 
comparing the average weighted impact scores of those participants registered 
blind, those registered partially sighted and those not registered as visually 
impaired. A Kruskal-Wallis test with post hoc Mann Whitney comparisons was 
carried out. There were significant differences between average weighted impact 
scores of those not registered and both the blind and the partially sighted groups 
(Table 4). There was no difference between the blind and the partially sighted 
groups. The analyses were repeated using only impact scores, with any impact 
score with a corresponding importance rating of zero recoded as zero (as used to 
investigate the rank order of domains, reported above). This method showed 
slightly less sensitivity to subgroup differences but, in this sample, the significance 
levels remained the same. The two overview items were also used to investigate 
differences between the three groups. They were found to be less sensitive than 
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the average weighted impact score (Table 4), although they did indicate the same 
differences that were shown using the average weighted impact score, with the 
exception that the generic item did not differentiate between the partially sighted 
group and those not registered. 
(Table 4 about here) 
 
Spearman’s correlations were carried out to investigate the association between 
the two-overview items and the average weighted impact score (Table 5). The 
highest correlation was between the MD-specific overview item and the average 
weighted impact score, although all the correlations were significant. 
 
(Table 5 about here) 
 
Discussion 
 
 
 
Members of the focus groups mentioned 12 of the original 19 domains of the 
MacDQoL spontaneously. This justified their inclusion in the measure for further 
evaluation and offered evidence of content validity. Additional evidence to support 
the inclusion of these and three new, spontaneously mentioned domains was 
provided in the reliability analysis. The internal consistency reliability coefficient 
alpha is a measure of the degree to which the items within the scale measure the 
same concept. Of the four domains that detracted from the alpha, only one had 
been mentioned spontaneously by participants (work). It is likely that ‘work’ did not 
contribute to the reliability because of the small number of people for whom it was 
applicable. The weighted impact scores of the remaining three detractors showed 
that they are not affected strongly by MD. The domain ‘finances’ was left in the 
measure for further investigation with a larger dataset. The reliability coefficient, 
after the removal of the domains (sex life and living conditions), is very satisfactory 
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(0.93). Nunnally and Bernstein [24] recommended an alpha level of >0.9 when a 
scale is used to assess individuals, and lower for use with groups.  
 
The findings illustrate that MD has a substantial negative impact on QoL. In this 
study, all but one of the domains showed a mean weighted impact of between –1 
and – 7.5. The altered rankings that resulted from weighting the impact ratings by 
the importance ratings show that weighting does, as expected from work on the 
ADDQoL (16), refine the measure. Such refinement is a characteristic of multi-
criteria decision making (25) and it is particularly valuable when the full range of 
importance ratings is used, as was the case in 14 of the 22 MacDQoL domains.  
This refinement allows a more accurate representation of individuals’ perceptions 
of the impact of MD on their QoL, since it reflects the individual variations in the 
perceived importance of each domain for QoL. Comparisons of scores obtained 
using the full range of weighting scores and those obtained by weighting using 
dichotomous rating of important versus not important showed that information is 
lost using the latter method. The differing rank order of domains produced by the 
two methods could have significant implications for clinical management. For 
example, identifying priorities in rehabilitation work with a patient might be done 
according to the rank order of the negative impact of MD on MacDQoL domains. 
Without the full range of weights being applied to impact scores, help may be given 
in an area that is of less importance to the patient and more important priorities 
overlooked. At a group level, the differences in ranks of domains produced by the 
two methods might result in less than optimal use of resources for rehabilitation. 
For example, in this sample,  ‘risk of mishaps and losing things’ is the third most 
negatively impacted domain using the weighted impact scores, but falls to sixth 
when differentiating only between no importance and any importance. Thus using 
the latter data, improving organisation and safety in the home might inappropriately 
be given a lower priority than increasing ease of travel. 
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There are arguments in the literature in favour of [3,4] and against [23] weighting of 
C-SQoL domains. Trauer and Mackinnon [26] said that there are conceptual issues 
associated with applying weights to scores of domains in QoL measures. They 
suggested that, since domains for a C-SQoL measure are generally selected 
because they are considered to be important to C-SQoL, it is tautologous to include 
importance weightings in the measure. In the study reported here, however, the full 
range of importance scores was used for 14 of the 22 domains, showing that 
domains of considerable importance to some individuals were not at all important to 
others.  
 
Comparing mean weighted impact scores for people with MD and people with 
diabetes on the domains common to the MacDQoL and the ADDQoL, there was a 
greater negative impact of MD than of diabetes in all but three domains (‘sex life’, 
‘enjoyment of food’ and ‘finances’). The findings of this study suggest that the 
seriousness of a condition, in terms of its potential to be life-threatening, does not 
necessarily correlate highly with its impact on C-SQoL and they illustrate the 
importance of measuring C-SQoL in all chronic medical conditions. 
 
The MacDQoL average weighted impact scores were sensitive to subgroup 
differences when used to compare participants registered blind, partially-sighted 
and those not registered. The finding that the average weighted impact score was 
more sensitive than either of the overview measures emphasises the benefits of the 
systematic assessment of the impact of MD on QoL in a way that captures the 
relevance of that impact to each individual. The two overview measures and the 
average weighted impact score were all correlated, and the overview items are 
sufficiently sensitive to be useful when a measure that is quickly and easily 
administered is required and would provide valuable information for health 
economists and planners. 
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The design of the MacDQoL ensures that it is condition-specific in two ways. First, 
domains impacted by MD and of importance to QoL were selected or suggested by 
people who have MD and are therefore of particular relevance for people with MD. 
Secondly, respondents to the questionnaire are asked specifically to consider the 
effect of MD on these domains. The importance of including items that are of 
particular relevance in MD is emphasised by the fact that six of the seven items that 
were either designed specifically for the MacDQoL (‘correspondence and personal 
affairs’, ‘mishaps and losing things’,  ‘shopping’, ‘household tasks’ and ‘time taken 
to do things’) or modified from the ADDQoL (hobbies and leisure activities’) are 
among the 10 most highly negatively impacted domains (Figure 3) in this sample. 
The MacDQoL is likely to be more sensitive to change than a generic measure. It is 
also more likely to differentiate between the effects of MD and the effects of other 
comorbidity, as has been found in the ADDQoL measure in comparison with the 
SF-36 [18]. Woodcock et al reported that the ADDQoL differentiated between the 
effects of complications of diabetes and the effects of unrelated comorbidity 
whereas the SF-36 did not. The issue of comorbidity is particularly important in an 
elderly population such as people with MD. 
 
In the present study only 17 participants (25%) were men, whereas in the MD 
population as a whole men account for about 33%. In future research, with larger 
samples, particular care will be taken to ensure that the properties of the MacDQoL 
make it equally suitable for assessing the impact of MD on QoL in men as well as 
women. 
 
During the focus groups some participants needed help to complete the MacDQoL. 
In this study, the need for help is confounded by severity of MD and it is not 
possible to isolate the possible effect of help on responses. In a forthcoming 
validation study respondents who are able to read the MacDQoL will be allocated 
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at random to interview or self-completion groups to allow the effect of different 
completion methods to be compared. 
 
Further developments 
 
 
 
The authors are also involved in developing a similar measure for use in diabetic 
retinopathy, the RetDQoL. The RetDQoL research team used in-depth interviews 
with 44 patients, 22 in UK and 22 in Germany, to determine questionnaire content 
and wording [27]. This collaboration has led to further changes to the MacDQoL, 
with the addition of new items. The wording of some items has been simplified, in 
particular the use of ‘I could’ instead of ‘my ability to’. The modification was 
suggested in the German translation but it works well in English too. Table 6 shows 
the domains and response options of the latest version of the MacDQoL, which will 
be evaluated psychometrically in future work. 
 
(Table 6 about here) 
 
 
Conclusions and recommendations 
 
The newly designed MacDQoL has been linguistically validated in 15 languages for 
use in a multinational clinical trial of a new treatment for wet MD. The psychometric 
development of the measure [28] will be carried out using data from that trial. In 
addition, validation of the measure outside a clinical trial will begin shortly. The 
internal consistency reliability must be sufficient to warrant combining scores into 
average weighted impact scores. The present study offers preliminary evidence of 
such reliability. The possibility of subscales will be investigated in future in larger 
samples using factor analysis and reliability analysis. The sensitivity to subgroup 
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differences reported here suggests that it is likely to be sensitive to change, and 
this will be investigated using data from the trial now in progress and in the 
forthcoming validation study.  
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If I did not have MD, my friendships and social life would be: 
• very much better………….……. -3 
• much better…………………….. -2 
• a little better……………………. -1 
• the same………………………..  0 
• worse…………………………….  1 
  
My friendships and social life are: 
• very important………………….  3 
• important……………………….  2 
• somewhat important……………  1 
• not at all important……………..  0 
  
Figure 1 
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Existing Domains 1st focus group          
(n = 6) 
2nd focus group 
(n = 11) 
household tasks # 2 4 
personal affairs # 4 4 
working life *  4 
family life * 2 2 
social life * 1 8 
physical appearance * 3 5 
physically do * 2 1 
sex life *   
Holidays ~   
Travelling * 4 11 
hobbies and leisure ~ 6 10 
Confidence *  1 
Motivation *   
society’s reaction *  1 
worries about future *   
Finances *   
Dependency * 1 5 
living conditions *   
enjoyment of food *   
Additional domains   
Shopping # 1 8 
mishaps/losses #  2 
time #  1 
# newly designed for MacDQoL; ~ modified from ADDQoL; * unchanged from ADDQoL 
Table 1   
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1st local 
group 
N = 6 
2nd local 
group 
N = 11 
Postal pilot 
study 
N = 47 
Electronic 
data collection 
trial N = 5 
1st draft 
3rd draft 
(2 domains 
removed: sex 
life, living 
conditions) 
2nd draft 
(3 domains 
added: 
shopping, 
mishaps, time) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2. 
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Mean 
impact 
score (s.d.) 
Min Max Mean 
importance 
rating (SD) 
Min Max Position 
in order 
of 
weighted 
impact 
        
1    work  -2.57 (0.79) -3 -1 2.86 (0.38) 2 3 1 
2    correspondence  -2.46 (0.93) -3 0 2.61 (0.63) 1 3 2 
3    travel  -2.38 (0.97) -3 0 2.49 (0.66) 0 3 4 
4    shopping  -2.31 (1.05) -3 0 2.18 (0.89) 0 3 6 
5    hobbies  -2.3 (0.88) -3 0 2.45 (0.74) 1 3 5 
6    mishaps, losing things  -2.24 (1.06) -3 0 2.54 (0.68) 1 3 3 
7    domestic tasks  -2.19 (0.91) -3 0 2.26 (0.75) 1 3 9 
8    dependency  -2.06 (1.11) -3 1 2.36 (0.81) 0 3 7 
9    confidence  -2.03 (1.01) -3 0 2.47 (0.74) 0 3 8 
10   time taken  2.02 (1.09) -3 1 2.27 (0.75) 1 3 10 
11   holidays  -2.02 (1.11) -3 0 2.03 (0.87) 0 3 15 
12   do things physically  -1.81 (1.00) -3 0 2.28 (0.70) 0 3 13 
13   worries about future  -1.77 (1.23) -3 1 2.03 (1.05) 0 3 14 
14   friends and social life  -1.75 (1.18) -3 1 2.43 (0.67) 1 3 12 
15   family life  -1.67 (1.15) -3 0 2.63 (0.60) 1 3 11 
16   motivation to do things -1.53 (1.15) -3 0 2.21 (0.80) 0 3 16 
17   society’s reaction  -1.03 (1.09) -3 1 1.94 (0.98) 0 3 17 
18   appearance  -0.97 (1.04) -3 0 1.88 (1.01) 0 3 18 
19   enjoyment of food  -0.89 (1.11) -3 0 1.80 (0.88) 0 3 19 
20   living conditions  -0.73 (0.99) -3 0 2.03 (0.92) 0 3 20 
21   finances  -0.49 (1.08) -3 1 1.78 (0.95) 0 3 21 
22   sex life  -0.27 (0.80) -3 0 1.6 (0.99) 0 3 22 
 
Table 2  
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Table 3 
Domain Correlation between 
impact and importance 
Correlation between 
impact and importance 
after removal of scores of 
0 for importance 
work -0.320 -0.320 
correspondence -0.195 -0.838 
travel -0.460 -0.911 
shopping -0.553 -0.861 
hobbies -0.601 -0.937 
mishaps, losing things -0.752 -0.967 
domestic tasks -0.648 -0.915 
dependency -0.677 -0.953 
confidence -0.436 -0.933 
time taken to do things -0.596 -0.926 
holidays -0.419 -0.828 
do things physically -0.527 -0.939 
worries about future -0.865 -0.973 
friends and social life -0.382 -0.934 
family life -0.258 -0.953 
motivation to do things -0.741 -0.965 
society’s reaction -0.587 -0.950 
appearance -0.551 -0.967 
enjoyment of food -0.279 -0.928 
living conditions -0.448 -0.954 
finances -0.473 -0.744 
sex life 
 
-0.422 -1.000 
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Kruskal-Wallis Test Mann Whitney Post hoc comparisons 
QoL Measure Chi-square, 
N ,  df &      
p-value 
Vision 
Category 
Comparison 
categories 
Mean 
difference 
Mann 
Whitney 
value 
Blind 2.66 52.0** Not 
registered P/s 2.34 86.0** 
Average 
weighted 
impact         
(Mean =-4.09) 
χ2 = 14.03 
N = 62,        
df = 2 
p< 0.001 Blind P/s -0.32 226.5 
Blind 0.81 70.0* Not 
registered P/s 0.66 123.5# 
MD-specific 
overview item      
( Mean = -2.32) 
χ2 = 9.36,       
N = 61,          
df = 2 
p < 0.01 Blind P/s -0.15 221.5 
Blind 1.14 70.0* Not 
registered P/s 0.42 157 
Generic 
overview item  
(Mean = 4.73) 
χ2 = 7.81,       
N = 61,          
df = 2, 
p < 0.05 Blind P/s -0.72 176.0 
** significant at p < 0.001; * significant at p < 0.01; # significant at p < 0.05 
 
 
Table 4 
 
 
 
Measure  Average weighted 
impact 
Generic QoL 
overview 
Generic QoL 
overview 
0.541* - 
MD-specific QoL 
overview 
0.688* 0.452* 
* significant at p < 0.01 
Table 5
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Table 6 
If I did not have MD,  
 
 1. I could handle my household tasks: (very much better – worse) 
 2. I could handle my personal affairs: (very much better – worse) 
 3. My experience of shopping would be: (very much better – worse) 
 4. *My working life and work-related opportunities would be: (very much better – 
worse) 
 5. My close personal relationship (e.g. marriage, living companion, steady 
relationship), now or in the future, would be: (very much better – worse) 
 6. *My family life would be: (very much better – worse) 
 7.  My friendships and social life would be: (very much better – worse) 
 8.  My physical appearance (including clothes and grooming) would be: (very much 
better – worse) 
 9.  Physically I could do: (very much more – less) 
10.  I could get out and about (e.g. on foot, or by car, bus or train): (very much 
better – worse) 
11.  *I would find long journeys: (very much easier – more difficult) 
12.  *My holidays would be: (very much better – worse) 
13.  I could pursue or enjoy my leisure activities (e.g. reading, TV, radio, cinema): 
(very much better – worse) 
14.  I could pursue or enjoy my hobbies or interests (e.g. sports, crafts, pets, 
gardening): (very much better – worse) 
15.  My self-confidence would be: (very much better – worse) 
16.  My motivation to achieve things would be: (very much better – worse) 
17.  The way people in general react to me would be: (very much better to worse) 
18.  The way society at large reacts to me would be: (very much better – worse) 
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19.  My feelings about the future (e.g. worries, hopes) would be: (very much better 
– worse) 
20.  My financial situation would be: (very much better – worse) 
21.  I would have to depend on others when I do not want to: (very much less – 
more) 
22.  I could do things for others as I wish: (very much better – worse) 
23.  I would have mishaps or would lose things: (very much less – more) 
24.  My enjoyment of food would be: (very much increased – decreased) 
25.  The time it takes me to do things would be: (very much less – more) 
26.  I could enjoy nature: (very much more – less) 
NB * Indicates ‘not applicable’ option 
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Table and figure captions 
 
Figure 1. Format of the domain-specific items (with scoring indicated) 
 
 
Table 1. Domains of 1st and 2nd drafts of MacDQoL and number of times listed 
spontaneously by members of two local MDS groups. 
 
 
Figure 2. Participants taking part at each stage of development of the 
MacDQoL and summary of changes to domains in drafts 2 and 3 
 
 
Table 2. Domains of MacDQoL in descending order of impact of MD on QoL, 
mean impact scores (sd), mean importance ratings (sd) and position of 
domains in order of impact. 
 
Figure 3.  Mean weighted impact scores of domains of MacDQoL 
 
 
Figure 4.  Mean weighted impact scores of domains common to ADDQoL and 
MacDQoL second draft 
 
Table 3  Correlations between impact and importance scores and between 
weighted impact and importance scores after removal of cases with zero in 
either variable 
 
Table 4.  Comparison of QoL scores of people registered blind, partially 
sighted and not registered (Kruskal-Wallis tests and Mann Whitney post hoc 
comparisons): MacDQoL average weighted impact scores, MD-specific QoL 
overview item scores and generic QoL overview item scores. 
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Table 5 Correlations between MacDQoL average weighted impact, generic 
QoL overview and MD-specific overview. 
 
Table 6. Domains contained in latest version of MacDQoL*, and response 
options.  
 
*MacDQoL © Prof Clare Bradley: 1.7.00.  
English for UK (standard). Latest revision 31.01.02.  
Health Psychology Research, Department of Psychology, Royal Holloway, 
University of London, Egham, Surrey, TW20 0EX 
